CIBUS INC (CBUS) Fundamental Analysis & Valuation

NASDAQ:CBUS • US17166A1016

Current stock price

1.831 USD
-0.05 (-2.61%)
Last:

This CBUS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CBUS Profitability Analysis

1.1 Basic Checks

  • CBUS had negative earnings in the past year.
  • CBUS had a negative operating cash flow in the past year.
  • CBUS had negative earnings in each of the past 5 years.
  • CBUS had a negative operating cash flow in each of the past 5 years.
CBUS Yearly Net Income VS EBIT VS OCF VS FCFCBUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M -250M

1.2 Ratios

  • The Return On Assets of CBUS (-41.66%) is comparable to the rest of the industry.
  • With a Return On Equity value of -582.18%, CBUS is not doing good in the industry: 76.98% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -41.66%
ROE -582.18%
ROIC N/A
ROA(3y)-54.21%
ROA(5y)-63.31%
ROE(3y)-315.39%
ROE(5y)-277.57%
ROIC(3y)N/A
ROIC(5y)N/A
CBUS Yearly ROA, ROE, ROICCBUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400 -500

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CBUS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBUS Yearly Profit, Operating, Gross MarginsCBUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5K -10K

0

2. CBUS Health Analysis

2.1 Basic Checks

  • CBUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CBUS has more shares outstanding than it did 1 year ago.
  • CBUS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CBUS has a worse debt to assets ratio.
CBUS Yearly Shares OutstandingCBUS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CBUS Yearly Total Debt VS Total AssetsCBUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of -4.41, we must say that CBUS is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CBUS (-4.41) is comparable to the rest of the industry.
  • CBUS has a Debt/Equity ratio of 10.77. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 10.77, CBUS is not doing good in the industry: 82.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 10.77
Debt/FCF N/A
Altman-Z -4.41
ROIC/WACCN/A
WACC5.94%
CBUS Yearly LT Debt VS Equity VS FCFCBUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 0.72 indicates that CBUS may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.72, CBUS is doing worse than 88.39% of the companies in the same industry.
  • A Quick Ratio of 0.72 indicates that CBUS may have some problems paying its short term obligations.
  • CBUS has a worse Quick ratio (0.72) than 88.20% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.72
CBUS Yearly Current Assets VS Current LiabilitesCBUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

4

3. CBUS Growth Analysis

3.1 Past

  • CBUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.48%, which is quite impressive.
  • The Revenue for CBUS has decreased by -14.62% in the past year. This is quite bad
  • CBUS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -31.34% yearly.
EPS 1Y (TTM)22.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.18%
Revenue 1Y (TTM)-14.62%
Revenue growth 3Y183.33%
Revenue growth 5Y-31.34%
Sales Q2Q%-12.79%

3.2 Future

  • Based on estimates for the next years, CBUS will show a very strong growth in Earnings Per Share. The EPS will grow by 28.28% on average per year.
  • CBUS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 150.09% yearly.
EPS Next Y35.71%
EPS Next 2Y19.94%
EPS Next 3Y30%
EPS Next 5Y28.28%
Revenue Next Year99.13%
Revenue Next 2Y104.5%
Revenue Next 3Y162.46%
Revenue Next 5Y150.09%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CBUS Yearly Revenue VS EstimatesCBUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M
CBUS Yearly EPS VS EstimatesCBUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -20 -40 -60

1

4. CBUS Valuation Analysis

4.1 Price/Earnings Ratio

  • CBUS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CBUS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBUS Price Earnings VS Forward Price EarningsCBUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBUS Per share dataCBUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CBUS's earnings are expected to grow with 30.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.94%
EPS Next 3Y30%

0

5. CBUS Dividend Analysis

5.1 Amount

  • No dividends for CBUS!.
Industry RankSector Rank
Dividend Yield 0%

CBUS Fundamentals: All Metrics, Ratios and Statistics

CIBUS INC

NASDAQ:CBUS (3/30/2026, 1:23:08 PM)

1.831

-0.05 (-2.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-17
Earnings (Next)05-06
Inst Owners17.36%
Inst Owner Change4.24%
Ins Owners24.88%
Ins Owner Change5.92%
Market Cap124.32M
Revenue(TTM)3.64M
Net Income(TTM)-127.08M
Analysts80
Price Target14.59 (696.83%)
Short Float %4.13%
Short Ratio4.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.47%
Min EPS beat(2)-34.52%
Max EPS beat(2)17.57%
EPS beat(4)2
Avg EPS beat(4)-3.28%
Min EPS beat(4)-34.52%
Max EPS beat(4)17.57%
EPS beat(8)3
Avg EPS beat(8)4.22%
EPS beat(12)3
Avg EPS beat(12)-144.79%
EPS beat(16)7
Avg EPS beat(16)-100.12%
Revenue beat(2)0
Avg Revenue beat(2)-46.82%
Min Revenue beat(2)-56.66%
Max Revenue beat(2)-36.97%
Revenue beat(4)0
Avg Revenue beat(4)-31.23%
Min Revenue beat(4)-56.66%
Max Revenue beat(4)-11.09%
Revenue beat(8)4
Avg Revenue beat(8)21.21%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.69%
EPS NQ rev (1m)11.11%
EPS NQ rev (3m)8.57%
EPS NY rev (1m)-0.45%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 34.16
P/FCF N/A
P/OCF N/A
P/B 5.7
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.38
EYN/A
EPS(NY)-1.53
Fwd EYN/A
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)-0.75
OCFYN/A
SpS0.05
BVpS0.32
TBVpS-3.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -41.66%
ROE -582.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-54.21%
ROA(5y)-63.31%
ROE(3y)-315.39%
ROE(5y)-277.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 10.77
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.76%
Cap/Sales 15.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.72
Altman-Z -4.41
F-Score3
WACC5.94%
ROIC/WACCN/A
Cap/Depr(3y)37.87%
Cap/Depr(5y)46.87%
Cap/Sales(3y)90.88%
Cap/Sales(5y)244.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.18%
EPS Next Y35.71%
EPS Next 2Y19.94%
EPS Next 3Y30%
EPS Next 5Y28.28%
Revenue 1Y (TTM)-14.62%
Revenue growth 3Y183.33%
Revenue growth 5Y-31.34%
Sales Q2Q%-12.79%
Revenue Next Year99.13%
Revenue Next 2Y104.5%
Revenue Next 3Y162.46%
Revenue Next 5Y150.09%
EBIT growth 1Y11.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.04%
EBIT Next 3Y42.29%
EBIT Next 5Y43.4%
FCF growth 1Y13.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.84%
OCF growth 3YN/A
OCF growth 5YN/A

CIBUS INC / CBUS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CIBUS INC?

ChartMill assigns a fundamental rating of 1 / 10 to CBUS.


What is the valuation status of CIBUS INC (CBUS) stock?

ChartMill assigns a valuation rating of 1 / 10 to CIBUS INC (CBUS). This can be considered as Overvalued.


Can you provide the profitability details for CIBUS INC?

CIBUS INC (CBUS) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for CBUS stock?

The Earnings per Share (EPS) of CIBUS INC (CBUS) is expected to grow by 35.71% in the next year.